#IPLaw Alert: Court Recognises Researcher's Moral Rights, But Dismisses Claim. Here's Why Your Collaboration Terms Matter

In the Malaysian High Court case of Veronica Sainik v. Meluha Life Sciences is a masterclass in how promising university-industry collaborations can unravel when intellectual property (IP) rights are not clearly defined from the outset.

While the case didn't make headlines for a multi-million dollar payout, it offers profound lessons for researchers, universities, and businesses alike.

The Case in a Nutshell

A researcher, Veronica Sainik, sued a biotechnology company, Meluha Life Sciences, claiming they used parts of her Master's dissertation to file a patent without her consent. She didn’t claim copyright infringement (as she had assigned those rights to her university), but instead invoked her "moral rights."

Moral rights, under Section 25 of the Malaysian Copyright Act 1987, are the author's non-economic rights to:

1. Be identified as the author (the right of paternity).
2. Object to any distortion or modification of their work that harms their honour or reputation (the right of integrity).

The Court's Landmark Holding: A Right Without a Remedy

The court made two critical findings:

1. The Right Was Invoked Correctly: The court affirmed that the researcher, as the author, does hold moral rights in her dissertation. These rights are separate from copyright and remain with the author even after the copyright itself is assigned to the university.
2. But There Was No Infringement: The court found that while the patent did contain modified parts of her dissertation, the researcher failed to prove that these modifications significantly altered her work or adversely affected her honour or reputation.

In essence, the court said, "You have the right, but you haven't shown that it was violated in the way the law requires." Her claim was dismissed.

Three Critical Takeaways for Your Next Collaboration

This judgment is a stark reminder that good intentions aren't enough. Here’s what you need to know:

1. For Businesses & Universities: Craft Your Collaboration Agreements Meticulously The judge expressed "anguish and sadness" over the management of this collaboration, noting "far too many shortcomings" and a lack of "clear directions and statement of terms and conditions." This is the heart of the problem.

Before a single experiment begins, agreements must explicitly address:

• Ownership of IP: Who owns what? Pre-existing IP? Foreground IP generated during the project?
• Student Rights & Obligations: What can a student use from the project for their thesis? What are the boundaries?
• Publication vs. Patenting: How are conflicts between the need to publish (for academia) and the need to patent (for industry) managed?
• Moral Rights: Can authors be required to waive their moral rights in certain contexts to facilitate commercialisation? This is a complex but crucial question.

2. For Researchers & Authors: Know Your Rights (And Their Limits) You must understand the difference between:

• Copyright: The economic right to reproduce and use the work. (Often assigned to the university).
• Moral Rights: The personal right to be credited and to protect the work's integrity. (Usually retained by you).

As this case shows, having a right is not the same as winning a case. The legal threshold for proving moral rights infringement is high. You must prove harm to your honour or reputation, which is often difficult.

3. For Everyone: Choose Your Legal Counsel Wisely As the poster wisely noted, "Not all lawyers know about IP." Intellectual property, especially in the niche area of academic moral rights, is highly specialised. Pursuing a claim without expert guidance from a lawyer well-versed in IP law can lead to a costly and disappointing outcome, as seen here.

Conclusion

The Veronica Sainik case is not just a legal ruling; it's a cautionary tale. It underscores that the most valuable IP asset is often not the invention itself, but the well-drafted agreement that governs the collaboration creating it.

For the sake of innovation, let's learn from this and ensure your partnerships are built on clarity, not just optimism.